SciDD Pharmaceuticals

Bringing preclinical drug candidates to clinical trials and then to market involves navigating a multi-stage process with significant challenges. Approximately only 1 percent of preclinical candidates will successfully reach the market. The journey typically takes 12 years and costs around $2 billion. Our advanced AI-powered data analytics platform allows for seamless comparison of preclinical candidates with previously published assets within the same preclinical models. By analyzing these data sets, the technology enables Pharmaceutical companies and investors to correlate preclinical results with clinical trial outcomes, providing crucial insights that enhance decision-making process. SciDD Pharmaceuticals - AI-powered data analytics for Scientific Due Diligence #dataanalytics #artificialintelligence #DueDiligence #PharmaIndustry #VentureCapital